XBiotech Inc

Financials

Cash from operating activities 65.15 M69.44 M14.82 M18.73 M30.96 M 23.51 M Cash from investing activities 3.73 M3.52 M63.89 M61.5 M1.3 M 339 K Cash from financing activities 409.72 M67.01 M09 00010.45 M 10.53 M Free cash flow 61.42 M65.92 M14.24 M18.36 M29.66 M 23.17 M

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

XBIT

Financials

XBiotech Inc

ニュース

XBiotech shareholders approve board nominees and key proposals at annual meeting

XBiotech appoints Thomas Kündig and Craig Rademaker to board of directors